Tabalumab, also as atacicept, represents a distinct medicinal strategy for addressing inflammatory diseases. This humanized monoclonal immunoglobulin primarily blocks B cell inducing factor BAFF, a key protein playing https://www.targetmol.com/compound/tabalumab